Oral findings in 50 children with neurofibromatosis type 1. A case control study

E Bardellini1, F Amadori, P Flocchini

  • 1University of Brescia, Dental Clinic, Brescia, Italy. bardalena@libero.it

Insights

Children with Neurofibromatosis type 1 (NF1) exhibit distinct oral health issues, including poor hygiene and jaw abnormalities. Early monitoring of oral manifestations in pediatric NF1 patients is crucial for long-term health outcomes.

Area of Science:

  • Pediatric Dentistry
  • Genetics
  • Oral Medicine

Background:

  • Limited data exists on oral manifestations in children with Neurofibromatosis type 1 (NF1).
  • NF1 is a genetic disorder affecting nerve tissue growth, with potential oral implications.
  • Understanding early oral signs in pediatric NF1 is essential for timely intervention.

Purpose of the Study:

  • To investigate and document the oral findings in a cohort of children diagnosed with NF1.
  • To compare oral health parameters in children with NF1 against a control group.
  • To identify specific dental and craniofacial characteristics associated with NF1 in childhood.

Main Methods:

  • A clinical research study involving 50 children with NF1 and a control group.
  • Comprehensive examinations of craniofacial structures, dental status, and oral tissues.
  • Assessment of dental caries, malocclusions, periodontal health, neurofibromas, and jaw abnormalities.
  • Statistical analysis using Unpaired Student's t test and Fisher's test (p <0.05 significance).

Main Results:

  • Children with NF1 demonstrated significantly poorer oral hygiene compared to controls.
  • Increased prevalence of Class III dental malocclusions was observed in the NF1 group.
  • Severe alterations in the mandible and temporomandibular joint were noted in children with NF1.

Conclusions:

  • Oral manifestations of NF1 are present in childhood, even before the development of classic neurofibromas.
  • Long-term follow-up is recommended for pediatric NF1 patients to monitor potential oral lesion development.
  • Early identification of oral findings in NF1 can guide management and improve patient outcomes.
Abstract